Company: AVCRF
Filing Date: 2025-06-16
Form Type: 20-F
Source: 0001641172-25-015266
Chunk: 16

Company: Avricore Health Inc.
Filing Date: 2025-06-16
Form: 20-F
Item: Item 5
Chunk 16
---
040                 61,569                 40,563  
  Insurance                                    90,633                 92,812                 60,251  
  Office maintenance                           43,089                 44,545                 31,888  
  Payroll                                      76,970                 70,495                 34,813  
  Regulatory fees                               1,131                  7,373                  5,238  
  Rent                                         27,100                 18,000                 16,800  
  Travel                                       95,338                 35,317                 55,170  
  Warranty expense                              9,750                  3,250                      -  
                                              409,398                339,369                250,144  

Share-based
compensation

Share-based
compensation for the year ended December 31, 2024 of $541,164 (2023: $703,612; 2022: $331,522) is a non-cash item that represents the
allocation of the fair value of options over the vesting period.

  17  

5.
B. Liquidity and capital resources

Liquidity

The
Company’s operations have been financed through the issuance of common shares. Management anticipates that additional financings
or capital requirements to fund the current commercial operations and working capital will be required to grow the business to the sustainable
level.

Cash
flows

Sources
and Uses of Cash:

                                               Year ended                             Year ended                            Year ended                         
                                               December 31, 2024                      December 31, 2023                     December 31, 2022                  
                                               $                                      $                                     $                                  
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Cash used in operating activities                                   (1,004,615                               660,403                               (437,832  
  Cash used in investing activities                                      205,347                             1,046,859                              1,208,516  
  Cash provided by financing activities                                   56,600                                42,500                                253,880  
  Net change in cash and cash equivalents                                855,868                              (343,956                             (1,392,468  
  Cash and Cash Equivalents                                            1,132,392                               276,571                                620,527  

Capital
resources

Management
devotes financial resources to the Company’s operations, sales and commercialization efforts,